The prevalence of the metabolic syndrome in psychiatric inpatients with primary psychotic and mood disorders

Psychosomatics

Volumn 47, Issue 6, 2006, Pages 491-497

  Bermudes, Richard A ^a   Keck Jr , Paul E ^b   Welge, Jeffrey A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTICLE; BODY MASS; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EARLY DIAGNOSIS; EDUCATION PROGRAM; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; METABOLIC SYNDROME X; MOOD DISORDER; NATIONAL CHOLESTEROL EDUCATION PROGRAM; PREVALENCE; PSYCHOSIS; RISK FACTOR;

EID: 33750489736     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.47.6.491     Document Type: Article

References (33)

1. Knutsen E, DuRand C: Previously unrecognized physical illness in psychiatric patients. Hosp Community Psychiatry 1991; 42:182-186
2. Lyketsos CG, Dunn G, Kaminsky MJ, et al: Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay. Psychosomatics 2002; 43:24-30
3. Brown S, Inskip H, Barraclough B: Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177:212-217
4. Osby U, Correia N, Brandt L, et al: Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophr Res 2000; 45:21-28
5. Lemipianinen P, Mykkanen L, Pyorala K, et al: Insulin-resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999; 100:123-128
6. Kekalainen P, Sarlund H, Pyorala K, et al: Hyperinsulinemia cluster predicts the development of Type 2 diabetes independent of a family history of diabetes. Diabetes Care 1999; 22:86-92
7. National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD, National Institutes of Health, 2001. NIH Publication 01-3670
8. Isomaa B, Amgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683-689
9. Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-2716
10. Park YW, Zhu S, Palaniappan L, et al: Prevalence and associated risk factor findings in the U.S. population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163:427-436
11. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among U.S. adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359
12. Heiskanen T, Niskanen L, Lyytikainen R, et al: Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 2003; 64:575-579
13. Kinder LS, Carnethon MR, Palaniappan LP, et al: Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004; 66:316-322
14. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994
15. McCaffery JM, Niaura R, Todaro JF, et al: Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute Twin Study. Psychosom Med 2003; 65:490-497
16. Davidson S, Judd F, Jolley D, et al: Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry 2001; 35:196-202
17. Brown S, Birtwistle J, Roe L, et al: The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999; 29:697-701
18. Atmaca M, Kuloglu M, Tezcan E, et al: Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics. J Clin Psychiatry 2003; 64:598-604
19. Haupt DW, Newcomer JW: Hyperglycemia and antipsychotic medications. J Clin Psychiatry 2001; 62(suppl27):15-26
20. Kasanin J: The blood sugar curve in mental disease. Arch Neurol Psychiatry 1926; 16:414-419
21. Meduna LJ, Gerty FJ, Urse VG: Biochemical disturbances in mental disorders. Arch Neurol Psychiatry 1942; 47:38-52
22. Ryan MCM, Flanagan S, Kinsella U, et al: The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naïve patients with schizophrenia. Life Sci 2004; 74:1999-2008
23. Thakore JH, Richards PJ, Rezneck RH, et al: Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 1997; 41:1140-1142
24. Siever LJ, Davis KL: Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 1985; 142:1017-1031
25. Kocsis JH, Davis JM, Katz MM, et al: Depressive behavior and hyperactive adrenocortical function. Am J Psychiatry 1985; 142:1291-1298
26. Jansen L, Gispen-de Wied CC, Gademan PJ, et al: Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr Res 1998; 33:87-94
27. Kudoh KA, Kudo T, Matsuki A: Depressed pituitary-adrenal response to surgical stress in chronic schizophrenic patients. Neuropsychobiology 1997; 36:112-116
28. Brunner EJ, Hemingway H, Walker BR, et al: Adrenocortical, antonomic, and inflammatory causes of the metabolic syndrome. Circulation 2002; 106:2659-2065
29. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 2004; 27:596-601
30. Casey DE, Haupt DW, Newcomer JW, et al: Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry 2004; 65(suppl7):4-18
31. Marder SR, Essock SM, Miller AL, et al: Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161:1334-1349
32. Keck PE Jr, Buse JB, Dagogo-Jack S, et al: Managing metabolic concerns in patients with severe mental illness: a special report. Postgrad Med, McGraw-Hill, Minneapolis, MN, 2003: pp 1-92
33. Prevalence Among U.S. Adults of a Metabolic Syndrome Associated with Obesity: Findings from the Third NHANES Survey. Centers for Disease Control and Prevention. available at http://www.cdc.gov/nccdphp/dnpa/obesity/trend/ metabolic.htm